WallStreetZenWallStreetZen

NASDAQ: PALI
Palisade Bio Inc Stock Ownership - Who owns Palisade Bio?

Insider buying vs selling

Have Palisade Bio Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
John David FinleyCEO CFO Director2024-05-28607$4.76
$2.89kSell
Donald Allen WilliamsDirector2024-05-281,000$4.86
$4.86kBuy
Mitchell Lawrence JonesChief Medical Officer2024-05-28810$4.76
$3.86kSell
Mitchell Lawrence JonesChief Medical Officer2024-05-28461$4.76
$2.19kSell
John David FinleyCEO CFO Director2024-05-28467$4.76
$2.22kSell
John David FinleyCEO CFO Director2024-05-28959$4.76
$4.56kSell
John David FinleyCEO CFO Director2024-05-241,000$4.81
$4.81kBuy
John David FinleyCEO CFO Director2024-05-20666$4.97
$3.31kBuy
Mitchell Lawrence JonesCEO CFO Director2024-05-0690$8.46
$761.40Sell
Mitchell Lawrence JonesCEO CFO Director2024-05-0647$8.46
$397.62Sell

1 of 3

PALI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PALI insiders and whales buy or sell their stock.

PALI Shareholders

What type of owners hold Palisade Bio Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Richard Garr211.86%1,986,304$9.57MInsider
Regional Medical Center Yuma193.52%1,814,375$8.75MInsider
Princeton Capital Corp138.00%1,293,814$6.24MInsider
Stanley Westreich127.27%1,193,281$5.75MInsider
Karl Johe99.23%930,373$4.48MInsider
Armistice Capital LLC76.79%720,000$3.47MInstitution
Robert J. Trenschel33.64%315,399$1.52MInsider
Sandford D. Smith23.46%219,916$1.06MInsider
John Conron12.32%115,492$556.67kInsider
Catherine A. Sohn11.41%106,952$515.51kInsider

1 of 3

PALI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PALI10.12%89.88%Net BuyingNet Selling
ONCO10.70%21.37%
ARTL0.77%25.83%
ENSC3.95%56.03%
TOVX4.58%1.45%Net Buying

Palisade Bio Stock Ownership FAQ

Who owns Palisade Bio?

Palisade Bio (NASDAQ: PALI) is owned by 99.22% institutional shareholders, 881.58% Palisade Bio insiders, and 0.00% retail investors. Richard Garr is the largest individual Palisade Bio shareholder, owning 1.99M shares representing 211.86% of the company. Richard Garr's Palisade Bio shares are currently valued at $9.57M.

If you're new to stock investing, here's how to buy Palisade Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.